Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: TROXEVASIN
Active substances:
Estonian, English, Latin
ATC code: C05CA04
Dosage form: capsule, hard
Strength: 300mg
Legal status for supply*: Not subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 18, 2023)
Package information leaflet (PIL): EST  (last updated May 18, 2023)
Translation of package information leaflet into Russian: RUS  (last updated February 21, 2023)
Translation of package information leaflet into English: ENG  (last updated February 21, 2023)
Labelling:  (last updated May 18, 2023)
Indication: Adjunctive treatment of oedema caused by chronic venous insufficiency of lower limbs.
Safety features: No
Marketing authorization holder: Teva B.V. 
Marketing authorization number: 409203 
Marketing authorization issued on: April 4, 2003 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1032859  TROXEVASIN  capsule, hard  300mg 50TK  OTC      19.02.2024     
1599554  TROXEVASIN  capsule, hard  300mg 100TK  OTC      19.02.2024     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere